StartseiteFachärzte, angestelltDr. med. Nadezda Gut

Dr. med. Nadezda Gut

Studium:
1994 – 2001 Studium der Humanmedizin, Turkmenisches staatliches medizinisches Institut (TSMI),
Aschgabat, Turkmenistan
2001 Approbation als Arzt (Turkmenistan)
2009 Approbation als Arzt (Deutschland)
Beruflicher Werdegang:
2001 – 2003 Abteilung Kinderpathologie
Institut für Pathologie, Aschgabat, Turkmenistan
2003 – 2004 Gastärztin / Stipendiatin
Institut für Allgemeine Pathologie und Pathologische Anatomie
Klinikum rechts der Isar, München (D)
(Leiter: Prof. Dr. med. Heinz Höfler)
2005 – 2007 Gastärztin / Stipendiatin
Pathologisches Institut der Ruprecht-Karls-Universität Heidelberg (D)
(Leiter: Prof. Peter Schirmacher)
02.2008 Promotion zum Dr. med.
Universitätsklinik Heidelberg (D)
2008 – 2012 Wissenschaftliche Mitarbeiterin/Assistenzärtin im NCT Gewebebank
Pathologisches Institut, Universitätsklinik Heidelberg (D)
(Leiter: Prof. Peter Schirmacher)
2009
(f. 6 Monate)
ERA-EDTA (European Renal Association–Europ. Dialysis and Transplant Association)
Stipendiatin im wissenschaftlichen Labor der Stereologie und Elektronmikroskopie
MIND Zentrum, Universität Aarhus, Dänemark
(Leiter: Prof. Jens Randel Nyengaard)
2013 – 2015 Assistenzärztin
Institut für Allgem. Pathologie med. Universität Innsbruck, Österreich
(Leiter: Prof. Dr. med. Heinz Regele, ab 01.2014 Prof. Dr. Christian Ensinger, ab 11.2014 Prof. Irene Esposito)
2015 – 2020 Abteilung für Pathologie Klinikum Memmingen (D)
(Chefarzt Dr. med. W. J. Hofmann)
2016 Fachärztin für klinische Pathologie und Molekularpathologie (Österreichische Ärztekammer)
Fachärztin für Pathologie (Bayerische Landesärztekammer)
seit 04.2020 Institut für Pathologie Kaufbeuren-Ravensburg
Forschungspreise:
2007 1. Poster-Preis am Weltkongress für Nephrologie
Rio de Janeiro, Brasilien
2009 Young Investigator Award, 33. Wissenschaftlichen Kongress der Deutschen Hochdruckliga e. V. DHL, Lübeck (D)
Mitgliedschaften:
Bundesverband Deutscher Pathologen
Deutsche Sektion der internationalen Akademie für Pathologie (IAP)
Österreichische Gesellschaft für klinische Pathologie und Molekularpathologie (ÖGPath)
Publikationen (Dr. med. Nadezda Gut geb. Koleganova):
2015 1. Slabiak-Blaz N, Adamczak M, Gut N, Grajoszek A, Nyengaard JR, Ritz E, Wiecek A Administration of Cyclosporine A in Pregnant Rats – the Effect on Blood Pressure and on the Glomerular Number in Their Offspring. Kidney Blood Press Res. 2015;40(4):413-23. doi: 10.1159/000368515. Epub 2015 Jul
2. Kronbichler A, Gut N, Zwerina J, Neuwirt H, Rudnicki M, Mayer G. Extending the spectrum of a chameleon: IgG4-related disease appearing as interstitial nephritis and mimicking anti-neutrophil cytoplasmic antibody-associated vasculitis.Rheumatology (Oxford). 2015 Oct;54(10):1936-8. doi: 10.1093/rheumatology/kev248. Epub 2015 Jul 9.
3. Cortina G, Trojer R, Waldegger S, Schneeberger S, Gut N, Hofer J. De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus. Pediatr Nephrol. 2015 Jan 12. (IF: 2,88)
2013 1. Gut N, Piecha G, Pradel A, Geldyyev A, Potemkina A, Ritz E, Regele H, Schmitt CP, Gross-Weissmann ML. The calcimimetic R-568 prevents podocyte loss in uninephrectomized ApoE -/- mice. Am J Physiol Renal Physiol. 2013 May 22. (IF: 4,42)
2. Gut N, Piecha G, Aldebssi F,· Schaefer S,· Bekeredjian R,· Schirmacher P,· Ritz E,· Gross-Weissmann M.-L. Erythropoietin Combined with ACE Inhibitor Prevents Heart Remodeling in 5/6 Nephrectomized Rats Independently of Blood Pressure and Kidney Function. Am J Nephrol 2013;38:124-135 (DOI: 10.1159/000353106) http://www.karger.com/DOI/10.1159/000353106 (IF: 2,623)
2012 1. Koleganova N, Piecha G, Slabiak-Blaz N, Ritz E. Prenatal causes of kidney diseases. AJN African Journal of Nephrology, 2012,
2. Koleganova N, Piecha G, Ritz E, Müller A, Fedorova OV, Bagrov AY, Lutz D, Schirmacher P, Gross-Weissmann ML. High salt intake causes adverse fetal programming–vascular effects beyond blood pressure. Nephrol Dial Transplant. 2012 Mar 19. (IF: 3,396)
3. Herpel E, Koleganova N, Schreiber B, Walter B, Kalle CV, Schirmacher P. Structural requirements of research tissue banks derived from standardized project surveillance. Virchows Arch. 2012 Jul;461(1):79-86. (IF: 2,491)
4. Koleganova N, Benz K, Piecha G, Ritz E, Amann K. Renal, cardiovascular and metabolic effects of fetal programming. Nephrol Dial Transplant. 2012 Aug;27(8):3003-7. (IF: 3,396)
2011 1. Kummer S, Jeruschke S, Wegerich LV, Peters A, Lehmann P, Seibt A, Mueller F, Koleganova N, Halbenz E, Schmitt CP, Bettendorf M, Mayatepek E, Gross-Weissmann ML, Oh J. Estrogen receptor alpha expression in podocytes mediates protection against apoptosis in-vitro and in-vivo. PLoS One. 2011;6(11):e27457. Epub 2011 Nov 11. (IF: 4,092)
2. Schmitt M, Höfler D, Koleganova N, Pawlita M. Human polyomaviruses and other human viruses in neuroendocrine tumors. Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1558-61. Epub 2011 May 25. (IF: 4,123)
3. Koleganova N, Piecha G, Ritz E, Becker LE, Müller A, Weckbach M, Nyengaard JR, Schirmacher P, Gross-Weissmann ML. Both high and low maternal salt intake in pregnancy alter kidney development in the offspring. Am J Physiol Renal Physiol. 2011 Aug; 301(2):F344-54. Epub 2011 May 18. (IF: 4,42)
4. Ritz E, Amann K, Koleganova N, Benz K. Prenatal programming-effects on blood pressure and renal function. Nat Rev Nephrol. 2011 Mar;7(3):137-44. Epub 2011 Feb 1. Review. (IF: 7,092)
5. Becker LE, Koleganova N, Piecha G, Noronha IL, Zeier M, Geldyyev A, Kökeny G, Ritz E, Gross ML. Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice. Am J Physiol Renal Physiol. 2011 Mar;300(3):F772-82. Epub 2010 Dec 15. (IF: 4,42)
6. Ritz E, Koleganova N, Piecha G.Is there an obesity-metabolic syndrome related glomerulopathy? Curr Opin Nephrol Hypertens. 2011 Jan;20(1):44-9. Review. Erratum in: Curr Opin Nephrol Hypertens. 2011 Mar;20(2):209. (IF: 4,331)
2010 1. Ritz E, Koleganova N, Heidland A. Renal research in 19th century Germany. Am J Kidney Dis. 2010 (IF: 5,434)
2. Ritz E, Koleganova N. African Americans compared to Senegalese–same number of glomeruli, but greater glomerular size. What does this tell us? Nephrol Dial Transplant. 2010 May;25(5):1368-70. (IF: 3,568)
3. Ritz E, Koleganova N. Aldosterone in Uremia – Beyond Blood Pressure. Blood Purif. 2010;29(2):111-113 (IF: 1,748)
4. Koleganova N, Piecha G, Ritz E. Vasculotropic effects of calcimimetics. Curr Opin Nephrol Hypertens. 2010 Jan;19(1):32-6. (IF: 4)
2009 1. Ritz E, Koleganova N, Obesity and chronic kidney disease. Semin Nephrol. 2009 Sep;29(5):504-11 (IF: 2,867)
2. Koleganova N, Piecha G, Ritz E, Schirmacher P, Müller A, Meyer HP, Gross ML. Arterial calcification in patients with chronic kidney disease. Nephrol Dial Transplant. 2009 Aug;24(8):2488-96. (IF: 3,568)
3. Nakagawa K, Parekh N, Koleganova N, Ritz E, Schaefer F, Schmitt CP. Acute cardiovascular effects of the calcimimetic R-568 and its enantiomer S-568 in rats. Pediatr Nephrol. 2009 Jul;24(7):1385-9 (IF: 2,321)
4. Koleganova N, Piecha G, Ritz E, Bekeredjian R, Schirmacher P, Schmitt CP, Gross ML. Interstitial fibrosis and microvascular disease of the heart in uremia: amelioration by a calcimimetic. Lab Invest. 2009 May;89(5):520-30 (IF: 4,58)
5. Koleganova N, Piecha G, Ritz E. Prenatal causes of kidney disease. Blood Purif. 2009;27(1):48-52. (IF: 1,748)
6. Ritz E, Koleganova N, Piecha G. Role of sodium intake in the progression of chronic kidney disease. J Ren Nutr. 2009 Jan;19(1):61-2. (IF: 1,204)
7. Koleganova N, Piecha G, Ritz E, Schmitt CP, Gross ML. A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia. Kidney Int. 2009 Jan;75(1):60-71. (IF: 6,418)
8. Koleganova N, Piecha G, Ritz E, Gross ML. Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats. Nephrol Dial Transplant. 2009 Mar;24(3):778-87. (IF: 3,569)
2008 1. Hadjicostas PT, Soucacos PN, Koleganova N, Piecha G, Krohmer G, Berger I. Comparative analysis of the microstructure of the hamstring tendons: an electron microscopic, histologic, and morphologic study. J Surg Orthop Adv. 2008 Fall;17(3):153-8.
2. Herpel E, Koleganova N, Schirmacher P.Tissue bank of the National Centre for Tumour Disease : An innovative platform for translational tumour. Pathologe. 2008 Oct 4. (IF: 0,424)
3. Piecha G, Koleganova N, Gross ML, Geldyyev A, Ritz E. Oxidative stress after uninephrectomy alters heart morphology in the apoE -/- mouse. J Hypertens. 2008 Nov;26(11):2220-9. (IF: 4,364)
4. Krohmer G, Koleganova N, Hagjicostas P, Fink B, Berger I. Degenerative changes of the interface membrane as a possible reason for prosthesis loosening. Histol Histopathol. 2008 Aug;23(8):925-33. (IF: 2,18)
5. Piecha G, Koleganova N, Gross ML, Geldyyev A, Adamczak M, Ritz E. Regression of glomerulosclerosis in subtotally nephrectomized rats – effects of monotherapy with Losartan, Spironolactone, and their combination. Am J Physiol Renal Physiol. 2008 Apr 23 (IF: 4,416)
6. Piecha G, Kokeny G, Nakagawa K, Koleganova N, Geldyyev A, Berger I, Ritz E, Schmitt CP, Gross ML. Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized rats. Am J Physiol Renal Physiol. 2008 Apr;294(4):F748-57 (IF: 4,416)
2007 1. Berger I, Piecha G, Rabkin R, Kaya N, Geldyyev A, Sun D, Chen Y, Koleganova N, Gross ML. Growth hormone treatment prevents osteoporosis in uremic rats. Histol Histopathol. 2007 Nov;22(11):1231-9. (IF: 2,182)
2. Hadjicostas P.T., Soucacos P.N., Paessler H.H., Koleganova N., Berger I. Morphologic and histologic comparison between the patella and hamstring tendons grafts: a descriptive and anatomic study. Arthroscopy. 2007 Jul;23(7):751-6. (IF: 1,574)
3. Hadjicostas PT, Soucacos PN, Berger I, Koleganova N, Paessler HH. Comparative analysis of the morphologic structure of quadriceps and patellar tendon: a descriptive laboratory study. Arthroscopy. 2007 Jul;23(7):744-50. (IF: 1,574)
4. Geldyyev A, Koleganova N, Piecha G, Sueltmann H, Finis K, Ruschaupt M, Poustka A, Gross ML, Berger I. High expression level of bone degrading proteins as a possible inducer of osteolytic features in pigmented villonodular synovitis. Cancer Lett. 2007 Jun 28 (IF:3,227)
2006 1. Bursztyn M, Gross ML, Goltser-Dubner T, Koleganova N, Birman T, Smith Y, Ariel I Adult hypertension in intrauterine growth-restricted offspring of hyperinsulinemic rats: evidence of subtle renal damage.Hypertension. 2006 Oct;48(4):717-23. Epub 2006 Aug 21. (IF: 6,331)
2003 1. A. Orazaliyeva, N. Koleganova, L. Schetinina, L.Kostrits. Features of immune system organs state in children under sepsis. Turkmenistanyn lukmancylygy, 10, 2003